16 Dec, 2020 10:24 AM
Institutional placement of up to 76,708,975 New Shares at an issue price of $0.036 per New Share to raise approximately $2.76 million (before costs).
For more information, download the attached P...read more
14 Dec, 2020 09:35 AM
The securities of Suda Pharmaceuticals Ltd (‘SUD’) will be placed in trading halt at the request of SUD, pending it releasing an announcement. Unless ASX decides otherwise, the securitie...read more
26 Nov, 2020 08:24 AM
Suda Pharmaceuticals Limited Annual General Meeting (AGM) will be held today, commencing at 11:00am AEDT, Thursday 26th November 2020.
For those shareholders and guests joining from other states,...read more
24 Nov, 2020 08:39 AM
SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oromucosal drug delivery, is pleased to advise that it has received a refund of $662,009 from the Australian Taxation Office under the R&D Tax In...read more
17 Nov, 2020 08:18 AM
SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, is pleased to announce that Dr Michael Baker is presenting at the Finance News Network Virtual Investor Event on 17 Novemb...read more
26 Oct, 2020 08:17 AM
SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, today released its Appendix 4C for the consolidated group for the first quarter of FY 2021.
Highlights
TGA approved r...read more
22 Sep, 2020 09:01 AM
SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, is pleased to announce that it has now received the final report for a canine pharmacokinetic study recently completed at ...read more
08 Sep, 2020 10:02 AM
SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, is pleased to announce that the Australian Patent Office has now accepted the patent application and the patent will proce...read more
05 Aug, 2020 01:41 PM
Institutional placement of up to 21,338,159 New Shares at an issue price of $0.025 per New Share to raise approximately $0.53 million (before costs)
For more information, please download the atta...read more
31 Jul, 2020 12:45 PM
SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oromucosal drug delivery, today released its Appendix 4C for the consolidated group for the fourth quarter of FY 2020.
Cash receipts for the quart...read more
29 Jul, 2020 08:57 AM
SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oromucosal drug delivery, is pleased to announce that the Therapeutics Goods Administration (TGA) has approved the registration of the Company’...read more
